CoV-ICU Score, Intensive Care Unit, SARS-CoV-2

CoV-ICU Score: Who Will Need Intensive Care in the Course of Corona Virus Disease?

In the course of COVID disease, some patients need intensive care treatment. We aim to find an answer to the question of whether the patient's CRP, ferritin, D-dimer, Oxygen Saturation, lymphocyte count, and body mass index can be used as a criterion for admitting patients with COVID to the intensive see unit.

Study Overview

• Status: Unknown
• Conditions: Coronavirus as the Cause of Diseases Classified Elsewhere
• Intervention / Treatment: Other: COVICU

Detailed Description

It is aimed to determine the patients who are above the threshold value to be determined according to this scoring result. Identifying patients who may need intensive care and following them closely will positively affect patient prognosis.

• Study Type: Observational
• Enrollment (Anticipated): 100

Contacts and Locations

• Study Contact: Name: Ali Asan, MD; Phone Number: +905332401067; Email: draasan@yahoo.com
• Study Contact Backup: Name: Erkan Sayan, MD; Phone Number: +905325972556; Email: erkansayan@hotmail.com

Study Locations

• Turkey
  • Yildirim
    • Bursa, Yildirim, Turkey, 16350
      • Recruiting
      • Bursa Yuksek Ihtisas Training and Research Hospital
      • Contact: Ali Asan, MD; Phone Number: +905332401067; Email: draasan@yahoo.com
      • Contact: Halil Erkan Sayan, MD; Phone Number: +905325972556; Email: erkansayan@hotmail.com
      • Principal Investigator: Nermin Kelebek Girgin, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

All patients admitted to the intensive care unit with the diagnosis of COVID

Description

Inclusion Criteria:

Patients admitted to the intensive care unit with the diagnosis of COVID

Exclusion Criteria:

<18 years patients

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
CoVID patients admitted to ICU; Patients admitted to the intensive care unit with the diagnosis of COVID	Other: COVICU; COVICU

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
COVICU score	With this scoring, identifying patients who may need intensive care early and following them closely will have a positive effect on patient prognosis.	1 week
Values	Minimum and maximum values will be determined at the end of the study. Higher scores mean a worse outcome	1 week

Collaborators and Investigators

• Sponsor: Bursa Yüksek İhtisas Education and Research Hospital
• Investigators: Principal Investigator: Ali Asan, MD, Bursa Yuksek Ihtisas Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): June 15, 2020
• Primary Completion (Anticipated): January 31, 2022
• Study Completion (Anticipated): February 28, 2022

Study Registration Dates

• First Submitted: May 7, 2020
• First Submitted That Met QC Criteria: May 7, 2020
• First Posted (Actual): May 12, 2020

Study Record Updates

• Last Update Posted (Actual): March 29, 2021
• Last Update Submitted That Met QC Criteria: March 26, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Keywords: SARS-CoV-2, intensive care
• Additional Relevant MeSH Terms: Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Coronavirus Infections
• Other Study ID Numbers: BYIEAH-202005

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: YES
• IPD Sharing Supporting Information Type: STUDY_PROTOCOL

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No